Literature DB >> 30853682

Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017).

Keiichi Fukuda1, Hiroshi Date2, Shozaburo Doi3, Yoshihiro Fukumoto4, Norihide Fukushima5, Masaru Hatano6, Hiroshi Ito7, Masataka Kuwana8, Hiromi Matsubara9, Shin-Ichi Momomura10, Masaharu Nishimura11, Hitoshi Ogino12, Toru Satoh13, Hiroaki Shimokawa14, Keiko Yamauchi-Takihara15, Koichiro Tatsumi16, Hatsue Ishibashi-Ueda17, Norikazu Yamada18, Shunji Yoshida19, Kohtaro Abe20, Aiko Ogawa9, Takeshi Ogo21, Takatoshi Kasai22, Masaharu Kataoka1, Takashi Kawakami1, Shigetoyo Kogaki23, Mashio Nakamura24, Tomotaka Nakayama25, Mari Nishizaki26, Koichiro Sugimura14, Nobuhiro Tanabe27, Ichizo Tsujino28, Atsushi Yao29, Takashi Akasaka30, Motomi Ando31, Takeshi Kimura32, Takayuki Kuriyama33, Norifumi Nakanishi34, Toshio Nakanishi35, Hiroyuki Tsutsui36.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30853682     DOI： 10.1253/circj.CJ-66-0158

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  19 in total

1.  Preprocedural frailty is strongly associated with symptoms after balloon pulmonary angioplasty.

Authors:  Nobutaka Ikeda; Raisuke Iijima; Hidehiko Hara; Yukio Hiroi; Masato Nakamura
Journal:  Glob Health Med       Date:  2022-02-28

Review 2.  Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team.

Authors:  Sofia Martin-Suarez; Antonio Loforte; Giulio Giovanni Cavalli; Gregorio Gliozzi; Luca Botta; Carlo Mariani; Valentina Orioli; Daniela Votano; Antonino Costantino; Valeria Santamaria; Sara Tassi; Costanza Fiaschini; Francesco Campanini; Massimiliano Palazzini; Barbara Rossi; Nicolò Antonino Barbera; Fabio Niro; Alessandra Manes; Francesco Saia; Fabio Dardi; Nazzareno Galiè; Davide Pacini
Journal:  Ann Cardiothorac Surg       Date:  2022-03

3.  Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis.

Authors:  Mengtao Li; Zhi-Cheng Jing; Yang Li; Yong Huo; Zaixin Yu; Gangcheng Zhang; Ping Zhu; Jinming Liu; Qiushang Ji; Bingxiang Wu; Jinhua Zhong; Pingping Wang; Wenjing Zhu; Xiaofeng Zeng
Journal:  BMC Cardiovasc Disord       Date:  2020-07-17       Impact factor: 2.298

4.  Multicentre randomised controlled trial of balloon pulmonary angioplasty and riociguat in patients with chronic thromboembolic pulmonary hypertension: protocol for the MR BPA study.

Authors:  Takashi Kawakami; Hiromi Matsubara; Kohtaro Abe; Masaharu Kataoka; Shun Kohsaka; Yasunori Sato; Toshiro Shinke; Keiichi Fukuda
Journal:  BMJ Open       Date:  2020-02-06       Impact factor: 2.692

Review 5.  Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension.

Authors:  Kazufumi Nakamura; Satoshi Akagi; Kentaro Ejiri; Masashi Yoshida; Toru Miyoshi; Norihisa Toh; Koji Nakagawa; Yoichi Takaya; Hiromi Matsubara; Hiroshi Ito
Journal:  Int J Mol Sci       Date:  2019-11-23       Impact factor: 5.923

6.  Protein expression profile changes of lung tissue in patients with pulmonary hypertension.

Authors:  Min Wu; Yijin Wu; Jinsong Huang; Yueheng Wu; Hongmei Wu; Benyuan Jiang; Jian Zhuang
Journal:  PeerJ       Date:  2020-01-31       Impact factor: 2.984

Review 7.  PTEN as a Therapeutic Target in Pulmonary Hypertension Secondary to Left-heart Failure: Effect of HO-3867 and Supplemental Oxygenation.

Authors:  Yazhini Ravi; Chittoor B Sai-Sudhakar; Periannan Kuppusamy
Journal:  Cell Biochem Biophys       Date:  2021-06-16       Impact factor: 2.194

8.  Results of Macitentan in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension　- A Prospective, Multicenter, Open-Label, Single-Arm, Phase 3 Study.

Authors:  Satomi Sakurai; Yoshifumi Ukyo
Journal:  Circ Rep       Date:  2021-06-09

9.  Deep learning to predict elevated pulmonary artery pressure in patients with suspected pulmonary hypertension using standard chest X ray.

Authors:  Kenya Kusunose; Yukina Hirata; Takumasa Tsuji; Jun'ichi Kotoku; Masataka Sata
Journal:  Sci Rep       Date:  2020-11-17       Impact factor: 4.379

10.  Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension.

Authors:  Mizuki Momoi; Takahiro Hiraide; Yoshiki Shinya; Hiromi Momota; Shogo Fukui; Michiyuki Kawakami; Yuji Itabashi; Keiichi Fukuda; Masaharu Kataoka
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.